Hoth Therapeutics Unveils $2 Mln Direct Offering Of Shares; Eyes Up To $4.4 Mln With Warrants

Hoth Therapeutics agreed to sell 2.85 million shares at $0.70 per share in a registered direct offering, raising approximately $2.0M gross. The funding provides incremental liquidity for the clinical-stage biopharma but is dilutive to existing shareholders; this is a company-specific financing with limited broader market impact.

Analysis

Hoth Therapeutics agreed to sell 2.85 million shares at $0.70 per share in a registered direct offering, raising approximately $2.0M gross. The funding provides incremental liquidity for the clinical-stage biopharma but is dilutive to existing shareholders; this is a company-specific financing with limited broader market impact.